H<sub>2</sub>O<sub>2</sub>-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28051306.
- Also identified by DOI 10.1021/acsnano.6b06892 and PMC identifier 5568789.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A self-regulated "smart" insulin administration system would be highly desirable for diabetes management. Here, a glucose-responsive insulin delivery device, which integrates H<sub>2</sub>O<sub>2</sub>-responsive polymeric vesicles (PVs) with a transcutaneous microneedle-array patch was prepared to achieve a fast response, excellent biocompatibility, and painless administration. The PVs are self-assembled from block copolymer incorporated with polyethylene glycol (PEG) and phenylboronic ester (PBE)-conjugated polyserine (designated mPEG-b-P(Ser-PBE)) and loaded with glucose oxidase (GOx) and insulin. The polymeric vesicles function as both moieties of the glucose sensing element (GOx) and the insulin release actuator to provide basal insulin release as well as promote insulin release in response to hyperglycemic states. In the current study, insulin release responds quickly to elevated glucose and its kinetics can be modulated by adjusting the concentration of GOx loaded into the microneedles. In vivo testing indicates that a single patch can regulate glucose levels effectively with reduced risk of hypoglycemia.
Medical subject headings
- Drug Delivery Systems
- Glucose
- Hydrogen Peroxide
- Hypoglycemia
- Insulin
- Transdermal Patch